Farms.com Home   News

ASABE Develops Standard for Specialty Crop Equipment

The American Society of Agricultural and Biological Engineers (ASABE) has initiated the development of a new standard for specialty crop equipment. S664, Direct to Consumption Specialty Crop Equipment Sanitary Design Requirements, will establish industry consensus sanitary design standards for specialty crop equipment that is used in direct-to-consumer specialty crop production.

This work began when FDA approached the Association of Equipment Manufacturers (AEM) to learn more about sanitary design of equipment that is used in the production of specialty crops. AEM worked with FDA to share information on the current state of the industry and understand some of the concerns that they had. In doing so equipment manufactures decided to be proactive in their approach and work with ASABE to help establish industry standards around sanitation for what is an emerging equipment market.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.